drugset / Trial / NCT05197530
Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)
Phase 1
Recruiting
40 enrolled
University of Rochester
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collabNational Institutes of Health (NIH) · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
Lymphatic transport was previously examined by these investigators using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities. They established reliable and reproducible methodologies in RA patients. The purpose of this phase 2 pilot is to study RA disease progression and effectiveness as well as the mechanism of action of clinical interventions using established NIR-ICG methodologies in previous studies.
Timeline
- Start
- 2021-12-30
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.1 ml | Other |